script.reportAU
Metabolic

Glycine with carbohydrate

Brand: Glycine500®

PBAC's latest decision on Glycine with carbohydrate: Recommended with restriction (2014). Considered for Dietary management of isovaleric acidaemia (IVA).

PBAC outcome
Recommended with restriction
Restricted
ICER (AUD/QALY)
Not modelled
no economic evaluation
Submissions
1
first 2014
Submissions
1
2014 → 2014

Eligible population

Patients with isovaleric acidaemia requiring dietary management.

Therapy area
Metabolic
Line of therapy
Not applicable
Evidence base
Other
Economic model
Not modelled
ICER note
not-modelled; this is a minor submission for a dietary supplement with no economic evaluation

Similar precedents

Open on full dashboard →